Advanced Search

Study Preview



Study Title and Description

Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.
Author Wei L., Lim SG., Xie Q., Văn KN., Piratvisuth T., Huang Y., Wu S., Xu M., Tang H., Cheng J., Le Manh H., Gao Y., Mou Z., Sobhonslidsuk A., Dou X., Thongsawat S., Nan Y., Tan CK., Ning Q., Tee HP., Mao Y., Stamm LM., Lu S., Dvory-Sobol H., Mo H., Brainard DM., Yang YF., Dao L., Wang GQ., Tanwandee T., Hu P., Tangkijvanich P., Zhang L., Gao ZL., Lin F., Le TTP., Shang J., Gong G., Li J., Su M., Duan Z., Mohamed R., Hou JL., Jia J.
Country Peking University People's Hospital, Beijing, China.
Year 2019
Numbers Pubmed ID: 30555048

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.